Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05458102
What this trial is testing

Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Gilead Sciences 18
Not applicableStudy completedNCT00014937
What this trial is testing

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Not applicableStudy completedNCT03284645
What this trial is testing

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids

Who this might be right for
Human Immunodeficiency Virus Infection
Obafemi Awolowo University 194
Not applicableStudy completedNCT04810559
What this trial is testing

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

Who this might be right for
HIV TestingHIV Infections
Unity Health Toronto 600
Testing effectiveness (Phase 2)Study completedNCT00002079
What this trial is testing

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

Who this might be right for
HIV Infections
G D Searle
Post-approval studies (Phase 4)Study completedNCT00976040
What this trial is testing

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis

Who this might be right for
Cryptococcal MeningitisHIV Infections
Botswana-UPenn Partnership 28
Early research (Phase 1)Ended earlyNCT07115368
What this trial is testing

Study of GS-1219 in Participants With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 4
Large-scale testing (Phase 3)Study completedNCT00450580
What this trial is testing

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV-1 Infection
ViiV Healthcare 212
Testing effectiveness (Phase 2)WithdrawnNCT00614640
What this trial is testing

Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02422797
What this trial is testing

Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)

Who this might be right for
HIV Infections
ViiV Healthcare 518
Testing effectiveness (Phase 2)Ended earlyNCT00095576
What this trial is testing

Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)

Who this might be right for
AIDSHIV Infections
Merck Sharp & Dohme LLC 3,000
Testing effectiveness (Phase 2)Study completedNCT01803074
What this trial is testing

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 107
Not applicableStudy completedNCT01771562
What this trial is testing

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Who this might be right for
HIV-1
ANRS, Emerging Infectious Diseases 330
Testing effectiveness (Phase 2)Study completedNCT00081588
What this trial is testing

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 555
Testing effectiveness (Phase 2)Study completedNCT00000820
What this trial is testing

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 104
Not applicableLooking for participantsNCT07725042
What this trial is testing

Analyses of Newly Diagnosed HIV Infection in Hong Kong

Who this might be right for
HIV -1 Infection
Chinese University of Hong Kong 720
Not applicableStudy completedNCT00720590
What this trial is testing

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Who this might be right for
Endothelial Dysfunction
Indiana University 30
Not applicableStudy completedNCT00016588
What this trial is testing

Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Gilead Sciences
Early research (Phase 1)Study completedNCT00040274
What this trial is testing

DPC 817 in HIV-Infected Males

Who this might be right for
HIV Infections
Pharmasset 30
Post-approval studies (Phase 4)UnknownNCT00120419
What this trial is testing

Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study)

Who this might be right for
HIV Infection
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 90
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation